That appears to be a reference to radiological markers that were found able to be used to identify mesenchymal expression. That of course will help identify more likely beneficiaries. Best wishes.
That means being able to identify with radiology in real time who is responding to DCVax rather than waiting for 5 year data. The optimal situation is that we know promptly whether a treatment is helping a specific patient so that management decisions can be made to optimize that patient’s outcome. It’s essentially my job.
Market Data 
Markets 
AI
